Abingdon Health announces £1M funding for the development of a quantitative rapid test Smartphone Reader -- MEDICA - World Forum for Medicine

17/09/2020

Abingdon Health

Abingdon Health announces £1M funding for the development of a quantitative rapid test Smartphone Reader

Innovate UK has released £1M to fund a further next generation development of Abingdon Health’s lateral-flow rapid test readout technology; AppDx®. The project will see the enhancement of AppDx® at an accelerated pace to achieve a fully quantitative smartphone-based solution for the lateral flow assay (LFA) market.

AppDx® is cutting-edge software that transforms a Smartphone camera into a self-sufficient, standalone lateral-flow reader. By utilising connectivity within Smartphones, AppDx® then enables data captured from rapid tests to be securely shared via a data cloud to connected stakeholders.

AppDx® algorithms work under a “bring-your-own-device” model and the software considers test specific and end-user variables as well as vital configuration criteria for different phone models.

Click on the link to read the full story.

Exhibitor Data Sheet